1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Venous (Vein) Thrombosis Global Clinical Trials Review, H2, 2014

Venous (Vein) Thrombosis Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, “Venous (Vein) Thrombosis Global Clinical Trials Review, H2, 2014" provides data on the Venous (Vein) Thrombosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Venous (Vein) Thrombosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Venous (Vein) Thrombosis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Venous (Vein) Thrombosis Global Clinical Trials Review, H2, 2014
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Venous (Vein) Thrombosis 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Venous (Vein) Thrombosis to Cardiovascular Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Venous (Vein) Thrombosis to Cardiovascular Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Venous (Vein) Thrombosis 25
Subjects Recruited Over a Period of Time 29
Clinical Trials by Sponsor Type 30
Prominent Sponsors 31
Top Companies Participating in Venous (Vein) Thrombosis Therapeutics Clinical Trials 32
Prominent Drugs 33
Clinical Trial Profiles 34
Clinical Trial Overview of Top Companies 34
Bayer AG 34
Clinical Trial Overview of Bayer AG 34
C. H. Boehringer Sohn AG and Co. KG 36
Clinical Trial Overview of C. H. Boehringer Sohn AG and Co. KG 36
GlaxoSmithKline plc 38
Clinical Trial Overview of GlaxoSmithKline plc 38
Pfizer Inc. 40
Clinical Trial Overview of Pfizer Inc. 40
Sanofi 41
Clinical Trial Overview of Sanofi 41
Bristol-Myers Squibb Company 42
Clinical Trial Overview of Bristol-Myers Squibb Company 42
Daiichi Sankyo Company, Limited 43
Clinical Trial Overview of Daiichi Sankyo Company, Limited 43
The LEO Foundation 44
Clinical Trial Overview of The LEO Foundation 44
AstraZeneca PLC 45
Clinical Trial Overview of AstraZeneca PLC 45
Astellas Pharma Inc. 46
Clinical Trial Overview of Astellas Pharma Inc. 46
Clinical Trial Overview of Top Institutes / Government 47
Brigham and Women's Hospital 47
Clinical Trial Overview of Brigham and Women's Hospital 47
Ottawa Hospital Research Institute 48
Clinical Trial Overview of Ottawa Hospital Research Institute 48
Academic Medical Center 49
Clinical Trial Overview of Academic Medical Center 49
Hamilton Health Sciences 50
Clinical Trial Overview of Hamilton Health Sciences 50
McMaster University 51
Clinical Trial Overview of McMaster University 51
University of Vermont 52
Clinical Trial Overview of University of Vermont 52
St. Orsola Hospital 53
Clinical Trial Overview of St. Orsola Hospital 53
Washington University School of Medicine 54
Clinical Trial Overview of Washington University School of Medicine 54
Centre Hospitalier Universitaire de Saint Etienne 55
Clinical Trial Overview of Centre Hospitalier Universitaire de Saint Etienne 55
Azienda Ospedaliera Universitaria Policlinico catania 56
Clinical Trial Overview of Azienda Ospedaliera Universitaria Policlinico catania 56
Five Key Clinical Profiles 57
Appendix 191
Abbreviations 191
Definitions 191
Research Methodology 192
Secondary Research 192
About GlobalData 193
Contact Us 193
Disclaimer 193
Source 193

List of Tables
Venous (Vein) Thrombosis Therapeutics, Global, Clinical Trials by Region, 2014* 7
Venous (Vein) Thrombosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Venous (Vein) Thrombosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Venous (Vein) Thrombosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Venous (Vein) Thrombosis Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Venous (Vein) Thrombosis Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Venous (Vein) Thrombosis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014* 13
Venous (Vein) Thrombosis Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014* 14
Proportion of Venous (Vein) Thrombosis to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 15
Venous (Vein) Thrombosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Venous (Vein) Thrombosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Venous (Vein) Thrombosis to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 18
Venous (Vein) Thrombosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Venous (Vein) Thrombosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Venous (Vein) Thrombosis Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Venous (Vein) Thrombosis Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Venous (Vein) Thrombosis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Venous (Vein) Thrombosis Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Venous (Vein) Thrombosis Therapeutics, Global, Suspended Clinical Trials, 2014* 25
Venous (Vein) Thrombosis Therapeutics, Global, Withdrawn Clinical Trials, 2014* 26
Venous (Vein) Thrombosis Therapeutics, Global, Terminated Clinical Trials, 2014* 27
Venous (Vein) Thrombosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 29
Venous (Vein) Thrombosis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 30
Venous (Vein) Thrombosis Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 31
Venous (Vein) Thrombosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 32
Venous (Vein) Thrombosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 33
Venous (Vein) Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2014* 34
Venous (Vein) Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by C. H. Boehringer Sohn AG and Co. KG, 2014* 36
Venous (Vein) Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014* 38
Venous (Vein) Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 40
Venous (Vein) Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014* 41
Venous (Vein) Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2014* 42
Venous (Vein) Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo Company, Limited, 2014* 43
Venous (Vein) Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by The LEO Foundation, 2014* 44
Venous (Vein) Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014* 45
Venous (Vein) Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Inc., 2014* 46
Venous (Vein) Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Brigham and Women's Hospital, 2014* 47
Venous (Vein) Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Ottawa Hospital Research Institute, 2014* 48
Venous (Vein) Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Academic Medical Center, 2014* 49
Venous (Vein) Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Hamilton Health Sciences, 2014* 50
Venous (Vein) Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by McMaster University, 2014* 51
Venous (Vein) Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Vermont, 2014* 52
Venous (Vein) Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by St. Orsola Hospital, 2014* 53
Venous (Vein) Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Washington University School of Medicine, 2014* 54
Venous (Vein) Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre Hospitalier Universitaire de Saint Etienne, 2014* 55
Venous (Vein) Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Azienda Ospedaliera Universitaria Policlinico catania, 2014* 56

List of Figures
Venous (Vein) Thrombosis Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Venous (Vein) Thrombosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Venous (Vein) Thrombosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Venous (Vein) Thrombosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Venous (Vein) Thrombosis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Venous (Vein) Thrombosis Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Venous (Vein) Thrombosis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014* 13
Venous (Vein) Thrombosis Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014* 14
Proportion of Venous (Vein) Thrombosis to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 15
Venous (Vein) Thrombosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Venous (Vein) Thrombosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Venous (Vein) Thrombosis to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 18
Venous (Vein) Thrombosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Venous (Vein) Thrombosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Venous (Vein) Thrombosis Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Venous (Vein) Thrombosis Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Venous (Vein) Thrombosis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Venous (Vein) Thrombosis Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Venous (Vein) Thrombosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 29
Venous (Vein) Thrombosis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 30
Venous (Vein) Thrombosis Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 31
Venous (Vein) Thrombosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 32
Venous (Vein) Thrombosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 33
GlobalData Methodology 192

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.